NR4A1 and breast cancer: Immunohistochemistry has advanced breast cancer prognosis and treatments by identifying hormone receptor (HR) oestrogen receptor (ER) and/or progesterone (PR) and human epidermal growth factor receptor HER2 pathways (Park et al. 2012; Dedes et al. 2011).